Ghisallo Capital Management »

Acelyrin shares owned by Ghisallo Capital Management

Quarter-by-quarter ownership of Acelyrin (SLRN) shares owned by Ghisallo Capital Management from 13F filings

Historical chart of Ghisallo Capital Management investment in Acelyrin

Tip: Access up to 7 years of quarterly data

All positions including Acelyrin held by Ghisallo Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acelyrin by Ghisallo Capital Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $712k 70k 10.17
2023-06-30 $1.5M 70k 20.90

More positions owned by Ghisallo Capital Management

Rollins (ROL)
Aercap Holdings Nv SHS (AER)
Arm Holdings Sponsored Adr (ARM)
Enbridge (ENB)
Kenvue (KVUE)
Alibaba Group Hldg Sponsored Ads (BABA)
Ge Healthcare Technologies I Common Stock (GEHC)
PG&E Corporation (PCG)
Jd.com Spon Adr Cl A (JD)
Core & Main Cl A (CNM)
Nextracker Class A Com (NXT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Corebridge Finl (CRBG)
Carlyle Group (CG)

View all positions for Ghisallo Capital Management

Top funds holding Acelyrin

Citadel Advisors
Vanguard Group
Opaleye Management
OrbiMed Advisors
venBio Partners
Jpmorgan Chase & Co
Artal Group
Samsara BioCapital
Ikarian Capital
Blue Owl Capital Holdings
Henderson Group
Decheng Capital
Logos Global Management
Kynam Capital Management
Goldman Sachs Group

View all funds holding Acelyrin